- Home
- BPMC vs PVH Comparison
BPMC vs PVH Comparison
Compare BPMC & PVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- PVH
- Stock Information
- Founded
- BPMC 2008
- PVH 1881
- Country
- BPMC United States
- PVH United States
- Employees
- BPMC N/A
- PVH N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- PVH Apparel
- Sector
- BPMC Health Care
- PVH Consumer Discretionary
- Exchange
- BPMC Nasdaq
- PVH Nasdaq
- Market Cap
- BPMC 5.8B
- PVH 6.1B
- IPO Year
- BPMC 2015
- PVH N/A
- Fundamental
- Price
- BPMC $99.18
- PVH $75.17
- Analyst Decision
- BPMC Buy
- PVH Buy
- Analyst Count
- BPMC 21
- PVH 15
- Target Price
- BPMC $124.05
- PVH $103.00
- AVG Volume (30 Days)
- BPMC 1.0M
- PVH 1.1M
- Earning Date
- BPMC 05-01-2025
- PVH 06-03-2025
- Dividend Yield
- BPMC N/A
- PVH 0.20%
- EPS Growth
- BPMC N/A
- PVH N/A
- EPS
- BPMC N/A
- PVH 10.56
- Revenue
- BPMC $562,121,000.00
- PVH $8,652,900,000.00
- Revenue This Year
- BPMC $44.85
- PVH $1.11
- Revenue Next Year
- BPMC $32.06
- PVH $2.25
- P/E Ratio
- BPMC N/A
- PVH $7.18
- Revenue Growth
- BPMC 99.19
- PVH N/A
- 52 Week Low
- BPMC $73.04
- PVH $59.28
- 52 Week High
- BPMC $121.90
- PVH $124.68
- Technical
- Relative Strength Index (RSI)
- BPMC 65.95
- PVH 59.95
- Support Level
- BPMC $97.91
- PVH $66.84
- Resistance Level
- BPMC $104.86
- PVH $76.81
- Average True Range (ATR)
- BPMC 3.74
- PVH 2.34
- MACD
- BPMC 1.50
- PVH 0.56
- Stochastic Oscillator
- BPMC 83.26
- PVH 86.86
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About PVH PVH Corp.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites and about 1,500 stores, licenses its brands to third parties, and distributes its merchandise through department stores and other wholesale accounts. The firm traces its history to 1881 and is based in New York City.